1-877-439-2744 Motherisk Helpline
1-800-436-8477 Morning Sickness
1-877-327-4636 Alcohol and Substance
1-866-937-7678 Exercise in Pregnancy
1-888-246-5840 HIV and HIV Treatment
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
- Read more in our News Archive
Current Studies at Motherisk
The Safety of Diclectin in Breastfeeding
Neurodevelopment of Children Exposed in-Utero to Chemotherapy for Maternal Breast Cancer (Dr. I Nulman)
Diclegis Surveillance Program Study
Diclectin Surveillance Program Study
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Alcohol Use during Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
The Cancer in Pregnancy ForumArchived Questions and Answers
This Forum has been the centre of an exceptional exchange of knowledge diagnosis, treatment, symptoms and other effects of cancer during pregnancy and lactation. All are welcome to review the Questions and Answers posted here, provided that they acknowledge and accept the important proviso and disclaimer below.
An otherwise healthy 30 y/o patient is scheduled for NECT of the sinuses to investigate chronic sinusitus (grade 8/10 by the patient).She discovers she is 4/12 pregnant at time of CT. Her management hinges on CT findings. If, according to table 1 in your website, fetal dose is less than 20 mREM for such an exam how would you counsel her with respect to substantive risk to the fetus?
Considering the distance between the facial and frontal sinuses and the fetus, a CT (at appropriate dose) of the sinuses is probably a safe procedure at this stage of pregnancy and should not compromise fetal health.